个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR (vol 9, 1016, 2018)

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Huang, Jun-ming[1] * ; Ren, Ran-yue[1] ; Bao,Yuan[1] ; Guo, Jia-chao[1] ; Xiang,Wei[1] ; Jing, Xing-zhi[1] ; Shi, Jia[1] ; Zhang, Guo-xiang[1] ; Li,Long[1] ; Tian, Yong[1] ; Kang,Hao[1] ; Guo, Feng-jin[1] ;
单位： [1]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Dept Orthoped,Wuhan,Hubei,Peoples R China
出处：
DOI： 10.3389/fphar.2018.01128
ISSN：

关键词： ulinastatin uPAR osteoclast MAPKs NF-kB RANKL osteoporosis

摘要：
[This corrects the article DOI: 10.3389/fphar.2018.01016.].

语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2017]版：
大类 | 2 区 医学
小类 | 2 区 药学
最新[2025]版：
大类 | 3 区 医学
小类 | 3 区 药学
JCR分区：
出版当年[2016]版：
Q1 PHARMACOLOGY & PHARMACY
最新[2023]版：
Q1 PHARMACOLOGY & PHARMACY

影响因子： 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者：
第一作者单位： [1]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Dept Orthoped,Wuhan,Hubei,Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Huang Jun-ming,Ren Ran-yue,Bao Yuan,et al.Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR (vol 9, 1016, 2018)[J].FRONTIERS IN PHARMACOLOGY.2018,9:doi:10.3389/fphar.2018.01128.
APA：
Huang, Jun-ming,Ren, Ran-yue,Bao,Yuan,Guo, Jia-chao,Xiang,Wei...&Guo, Feng-jin.(2018).Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR (vol 9, 1016, 2018).FRONTIERS IN PHARMACOLOGY,9,
MLA：
Huang, Jun-ming,et al."Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR (vol 9, 1016, 2018)".FRONTIERS IN PHARMACOLOGY 9.(2018)

相关文献

[1]Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR [2]Probucol suppresses osteoclastogenesis via activating Nrf2 signaling and ameliorates ovariectomy-induced bone loss [3]Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR (vol 8, 693, 2017) [4]Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR [5]Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR (vol 8, 693, 2017) [6]Bone-Targeted Biomimetic Nanogels Re-Establish Osteoblast/Osteoclast Balance to Treat Postmenopausal Osteoporosis [7]Inhibition of MAT2A suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss [8]Isofraxidin Inhibits Receptor Activator of Nuclear Factor-kappa B Ligand-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages Isolated from Sprague-Dawley Rats by Regulating NF-kappa B/NFATc1 and Akt/NFATc1 Signaling Pathways [9]Hesperetin suppresses RANKL-induced osteoclastogenesis and ameliorates lipopolysaccharide-induced bone loss [10]A potential therapeutic target for regulating osteoporosis via suppression of osteoclast differentiation

资源点击量：426 今日访问量：0 总访问量：408 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）